arrow
Return

Allergen immunotherapy

delete2010-02-01
delete161
PRE
AI
A
Anthony J. Frew *
DOI:10.1016/j.jaci.2009.10.064delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Specific immunotherapy (SIT) involves the administration of allergen extracts to achieve clinical tolerance of those allergens that cause symptoms in patients with allergic conditions. Immunotherapy is effective in patients with mild forms of allergic disease and also in those who do not respond well to standard drug therapy. Most SIT is given by means of injection, but there is increasing interest in performing SIT through the sublingual route. SIT remains the treatment of choice for patients with systemic allergic reactions to wasp and bee stings and should be considered as an option in patients with allergic rhinitis, asthma, or both. SIT can modify the course of allergic disease by reducing the risk of new allergic sensitizations and inhibiting the development of clinical asthma in children treated for allergic rhinitis. The precise mechanisms responsible for the beneficial effects of SIT remain a matter of research and debate. An effect on regulatory T cells seems most probable and is associated with switching of allergen-specific B cells toward IgG4 production. Few direct comparisons of SIT and drug therapy have been made. Existing data suggest that the effects of SIT take longer to develop, but once established, SIT achieves long-lasting relief of allergic symptoms, whereas the benefits of drugs only last as long as they are continued. (J Allergy Clin Immunol 2010;125:S306-13.)
Keywords:
Immunotherapy
immunomodulation
rhinitis
asthma
T cell
B cell
IgE
IgG
sublingual

Journal

Journal of Allergy and Clinical Immunology cover
Journal of Allergy and Clinical Immunology
IF:
11.2
Papers:
3.7W
Citations:
5.6W

Organization

No organization information available
Cited Papers

Cited Papers

errShare
errSave
Retinoic acid and dexamethasone induce differentiation and maturation of somatotroph cells at different stages in vitro
err2011-01-01
err0
errOAAI
errYu Cheng; Ying Xiang; Youzhi Lin; Songbin Fu; Wenzhi Jia; Guanghui Zhang; Wenming Lv; Shan Mi; Qinghai Zhao
errShare
errSave
Long-term clinical efficacy of grass-pollen immunotherapy
err1999-08-12
err1.1K
errOAAI
errDurham, SR; Walker, SM; Varga, EM; Jacobson, MR; O'Brien, F; Noble, W; Till, SJ; Hamid, QA; Nouri-Aria, KT
errShare
errSave
Ragweed immunotherapy in adult asthma
err1996-02-22
err187
errOAAI
errCreticos, PS; Reed, CE; Norman, PS; Khoury, J; Adkinson, NF; Buncher, CR; Busse, WW; Bush, RK; Gadde, J; Li, JT; Richerson, HB; Rosenthal, RR; Solomon, WR; Steinberg, P; Yunginger, JW
errShare
errSave
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
err2008-11-01
err278
PREAI
errPauli, Gabrielle; Larsen, Tina H.; Rak, Sabina; Horak, Friedrich; Pastorello, Elide; Valenta, Rudolph; Purohit, Ashok; Arvidsson, Monica; Kavina, Alexander; Schroeder, Jan W.; Mothes, Nadine; Spitzauer, Susanne; Montagut, Armelle; Galvain, Sylvie; Melac, Michel; Andre, Claude; Poulsen, Lars K.; Malling, Hans-Jorgen
errShare
errSave
Mechanisms of allergen specific immunotherapy - T-cell tolerance and more
err2006-06-15
err133
errOAAI
errJutel, M.; Akdis, M.; Blaser, K.; Akdis, C. A.
errShare
errSave
Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study
err2004-04-06
err132
PREAI
errBufe, A; Ziegler-Kirbach, E; Stoeckmann, E; Heidemann, P; Gehlhar, K; Holland-Letz, T; Braun, W
errShare
errSave
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity
err2008-05-01
err282
PREAI
errFrancis, James N.; James, Louisa K.; Paraskevopoulos, Giannis; Wong, Cheukyee; Calderon, Moises A.; Durham, Stephen R.; Till, Stephen J.
errShare
errSave
researcher View more